|
|
In honor of Doctors' Day on March 30, we recognize the significant contributions of physicians and their commitment to providing the most advanced, highest quality care for our cancer patients.
Providence Hood River, Providence Portland and Providence St. Vincent each earned Healthgrades honors for outstanding patient experience. Providence Medford was honored for patient safety excellence.
New trials available at Earle A. Chiles Research Institute for patients with human epidermal growth factor receptor 2 positive (HER2+) colorectal cancer and patients with cholangiocarcinoma.
In honor of Social Work Month we recognize the incredible contributions of oncology social workers.
Hitting the slopes can be a fun and healthy activity, but there can be risks. Dr. Christopher Van Tilburg, with the Providence Hood River Memorial Hospital Mountain Clinic, talks mountain safety.
A new trial offered at Providence Cancer Institute is enrolling patients with early-stage HR-positive and HER2-negative breast cancer.
As part of an international data-sharing consortium of leading cancer centers, Providence Cancer Institute and Swedish Cancer Institute work together to provide genomic data to Project GENIE.
Finding the right kind of care – at the right time and place – shouldn’t be difficult. We detail your options so you can easily determine which is best for YOU.
Using MRI-guided radiation, Providence radiation oncologists can precisely target tumors for destruction while minimizing damage to surrounding normal tissue.
For third year in a row, Providence St. Vincent Medical Center has received America’s 50 Best Hospitals Award. This recognition places Providence among the top 1% of the country's hospital
A new clinical trial offered at Providence Cancer Institute to study the safety and effectiveness of two different treatments for people under age 70 with previously untreated non-GCB DLBCL.
Providence Cancer Institute highlights a year of engaging with and supporting our patients, partner organizations and community.
Under guidance from the Oregon Health Authority, we have activated crisis standards of care in some care areas at Providence Oregon hospitals.
Many emergency rooms, clinics and urgent care centers are experiencing a sharp rise in the number of cases of RSV, flu and COVID.
Providence Cancer Institute is offering a phase III trial for patients with gynecologic cancers and two early phase trials that will study new medications in treating solid tumors.
The Providence Center for Weight Management's bariatric surgery program has been recognized for high-quality distinctions from Healthgrades.
Providence is seeing many children with RSV. Under guidance from OHA, we have activated crisis standards of care in pediatric units at Providence Portland Medical Center.
Providence currently accepting applications for an Immuno-Oncology Research Fellowship being offered through Earle A. Chiles Research Institute.
Bernard A. Fox, Ph.D., leader of the Laboratory of Molecular and Tumor Immunology honored by the Society for Immunotherapy of Cancer for legacy of public service.